In a sit-down interview at the annual J.P. Morgan Healthcare conference, Allen talked about a tool built by a company backed by General Catalyst and Andreessen Horowitz. The post One Healthcare AI Application that Intrigues Intermountain Health’s CEO appeared first on MedCity News.
Johnson & Johnson’s agreement to acquire Intra-Cellular Therapies brings Caplyta, which is projected to become a blockbuster seller across several neurological indications. In other M&A news, GSK and Eli Lilly each struck deals to fill their cancer drug pipelines. The post J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies appeared…
At JPM25, Nvidia announced four new partnerships focused on scaling AI models across the healthcare industry. The company is teaming up with Mayo Clinic, Illumina, IQVIA and Arc Institute. The post Nvidia Announces Partnerships with Mayo Clinic, Illumina & More at JPM25 appeared first on MedCity News.
There was a slight decrease in 2024 digital health venture funding compared to 2023, according to a new report from Rock Health. This partially due to increasing investor interest in earlier-stage startups. The post Rock Health: Digital Health Funding Drops in 2024, Investors Shift Focus to Early-Stage Startups appeared first on MedCity News.
Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations. The post Prioritize Provider Data for Seamless M&A Success appeared first on MedCity News.
AI is the next big thing, and most developers want to protect those programs and systems. The answer is intellectual property protection and specifically patent protection. The post AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive! appeared first on MedCity News.
Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…
HHS is proposing major changes to HIPAA for the first time in more than a decade, aiming to strengthen cybersecurity protocols for electronic health data. Healthcare cybersecurity leaders are mainly in favor of the proposal — though there are some concerns that smaller providers will struggle with the financial and operational burdens of compliance. The…
Implementing a thorough federal privacy law and broadening HIPAA protections to include new mHealth technologies are crucial steps in enhancing personal data security. Equally important, companies and developers should adhere to strict ethical standards and robust security protocols during app development to protect users’ sensitive information. The post Mental Health Data Sells, But Who’s Buying?…
AI holds a lot of promise in supporting employer-sponsored healthcare, including improving patient navigation and billing, according to a new report from Morgan Health. The post Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare appeared first on MedCity News.